Medullary Kidney Disease

Medullary Kidney Disease 1 Team

 Research team

The MKD1 Research Team (from left to right): Vicki Robins, Kendrah Kidd and Dr. Anthony J. Bleyer

About our research team:

Dr. Anthony J. Bleyer, MD, MS  has studied inherited kidney diseases for over 15 years. He attended Baylor College of Medicine in Houston, Texas and then did his internship and residency at Johns Hopkins Hospital, Baltimore, Maryland. He studied kidney disease and did laboratory research in kidney disease for one year at the University of Pennsylvania in Philadelphia, PA. He then joined the faculty at Wake Forest School of Medicine® and is now Professor of Kidney Disease, having been on the faculty for over 20 years.

He first became interested in research in inherited kidney disease when he studied a family with gout and kidney disease in western North Carolina. Working with Drs. Thomas and Suzanne Hart at the National Institutes of Health, he helped to identify the genetic cause of this disease (medullary cystic kidney disease type 2) as mutations in a gene encoding the protein uromodulin.  Since then he has worked to identify the genetic causes of kidney diseases in over 300 families from all over the world. He recently worked with scientists from the Broad Institute in Cambridge, MA to identify mutations in the MUC1 gene as a cause of MKD1.

Vicki Robins, RN, BSN received her BSN from the University of North Carolina at Chapel Hill and has over 30 years of experience as a nurse. She was a dialysis nurse for 10 years and has been a member of the research team with Dr. Bleyer since 2001.

Kendrah Kidd, MS has 14 years of research laboratory experience in biochemistry, kidney stone formation and joined the MKD1 research team in 2012.  She earned her MS in biology from Wake Forest University in Winston-Salem, NC.

About our research:

Our research team is working hard with many other doctors and scientists. Our goal is to find a cure or treatment for medullary kidney disease. One way we are trying to do this is to study as many patients with this disease as we can. For example, some individuals do not go on dialysis until late in life, while others go on dialysis when young. Why is there such a difference? We are hoping that by studying the people who have less severe disease, we can find clues that we can use to keep the kidneys working longer.

We often obtain blood and urine samples to study this condition. We work with scientists from all over the world, including the Broad Institute, Cambridge, MA, the University of Pittsburgh, Pittsburgh, PA, the National Institutes of Health, and the First Faculty of Medicine of the Charles University in Prague, Czech Republic.

We are also excited to be working with the Uromodulin Kidney Disease Foundation which provides support for families, doctors and researchers.  For more information, visit: ukdcure.org

To read more about our research, please go to MKD1 Research.

Last Updated: 04-07-2014
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.